Longevity Health Holdings Net Income
| XAGE Stock | 0.29 0.02 6.45% |
As of the 7th of February, Longevity Health secures the Mean Deviation of 6.2, standard deviation of 9.29, and Risk Adjusted Performance of (0.05). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Longevity Health Holdings, as well as the relationship between them. Please verify Longevity Health Holdings standard deviation, as well as the relationship between the treynor ratio and potential upside to decide if Longevity Health Holdings is priced some-what accurately, providing market reflects its recent price of 0.29 per share. As Longevity Health Holdings appears to be a penny stock we also strongly suggest to check its jensen alpha numbers.
Longevity Health Total Revenue |
|
Gross Profit | Market Capitalization | Enterprise Value Revenue 0.018 | Revenue | Earnings Share (5.10) |
| Last Reported | Projected for Next Year | ||
| Net Loss | -9.6 M | -10.1 M | |
| Net Loss | -10.6 M | -11.2 M | |
| Net Loss | (0.57) | (0.60) | |
| Net Income Per E B T | 1.11 | 1.05 |
Longevity | Net Income | Build AI portfolio with Longevity Stock |
Analyzing Longevity Health's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Longevity Health's current valuation and future prospects.
Latest Longevity Health's Net Income Growth Pattern
Below is the plot of the Net Income of Longevity Health Holdings over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Longevity Health Holdings financial statement analysis. It represents the amount of money remaining after all of Longevity Health Holdings operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Longevity Health's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Longevity Health's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (11.8 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Longevity Net Income Regression Statistics
| Arithmetic Mean | (7,749,482) | |
| Coefficient Of Variation | (31.25) | |
| Mean Deviation | 1,793,731 | |
| Median | (6,478,923) | |
| Standard Deviation | 2,421,854 | |
| Sample Variance | 5.9T | |
| Range | 9M | |
| R-Value | (0.64) | |
| Mean Square Error | 3.7T | |
| R-Squared | 0.41 | |
| Significance | 0.01 | |
| Slope | (306,316) | |
| Total Sum of Squares | 93.8T |
Longevity Net Income History
Other Fundumenentals of Longevity Health Holdings
Longevity Health Net Income component correlations
Longevity Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Longevity Health is extremely important. It helps to project a fair market value of Longevity Stock properly, considering its historical fundamentals such as Net Income. Since Longevity Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Longevity Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Longevity Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Biotechnology sector continue expanding? Could Longevity diversify its offerings? Factors like these will boost the valuation of Longevity Health. Anticipated expansion of Longevity directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Longevity Health data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Longevity Health Holdings using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Longevity Health's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Longevity Health's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Longevity Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Longevity Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Longevity Health's market price signifies the transaction level at which participants voluntarily complete trades.
Longevity Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Longevity Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Longevity Health.
| 11/09/2025 |
| 02/07/2026 |
If you would invest 0.00 in Longevity Health on November 9, 2025 and sell it all today you would earn a total of 0.00 from holding Longevity Health Holdings or generate 0.0% return on investment in Longevity Health over 90 days. Longevity Health is related to or competes with Celularity, ZyVersa Therapeutics, Concord Medical, Aditxt, INVO Fertility, Shineco, and Lixte Biotechnology. Longevity Health is entity of United States More
Longevity Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Longevity Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Longevity Health Holdings upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 46.8 | |||
| Value At Risk | (18.75) | |||
| Potential Upside | 18.6 |
Longevity Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Longevity Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Longevity Health's standard deviation. In reality, there are many statistical measures that can use Longevity Health historical prices to predict the future Longevity Health's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.69) | |||
| Total Risk Alpha | (1.57) | |||
| Treynor Ratio | (1.21) |
Longevity Health February 7, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (1.20) | |||
| Mean Deviation | 6.2 | |||
| Coefficient Of Variation | (1,458) | |||
| Standard Deviation | 9.29 | |||
| Variance | 86.34 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.69) | |||
| Total Risk Alpha | (1.57) | |||
| Treynor Ratio | (1.21) | |||
| Maximum Drawdown | 46.8 | |||
| Value At Risk | (18.75) | |||
| Potential Upside | 18.6 | |||
| Skewness | 0.066 | |||
| Kurtosis | 1.28 |
Longevity Health Holdings Backtested Returns
Longevity Health Holdings has Sharpe Ratio of -0.0717, which conveys that the firm had a -0.0717 % return per unit of risk over the last 3 months. Longevity Health exposes twenty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Longevity Health's Standard Deviation of 9.29, risk adjusted performance of (0.05), and Mean Deviation of 6.2 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.53, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Longevity Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Longevity Health is expected to be smaller as well. At this point, Longevity Health Holdings has a negative expected return of -0.68%. Please make sure to verify Longevity Health's potential upside, as well as the relationship between the rate of daily change and price action indicator , to decide if Longevity Health Holdings performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.47 |
Average predictability
Longevity Health Holdings has average predictability. Overlapping area represents the amount of predictability between Longevity Health time series from 9th of November 2025 to 24th of December 2025 and 24th of December 2025 to 7th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Longevity Health Holdings price movement. The serial correlation of 0.47 indicates that about 47.0% of current Longevity Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.47 | |
| Spearman Rank Test | 0.35 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Longevity Health Holdings reported net income of (11.8 Million). This is 101.07% lower than that of the Biotechnology sector and 101.18% lower than that of the Health Care industry. The net income for all United States stocks is 102.07% higher than that of the company.
Longevity Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Longevity Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Longevity Health could also be used in its relative valuation, which is a method of valuing Longevity Health by comparing valuation metrics of similar companies.Longevity Health is currently under evaluation in net income category among its peers.
Longevity Fundamentals
| Return On Asset | -1.19 | ||||
| Operating Margin | (3.51) % | ||||
| Current Valuation | 26.29 K | ||||
| Shares Outstanding | 1.78 M | ||||
| Shares Owned By Insiders | 11.30 % | ||||
| Shares Owned By Institutions | 2.94 % | ||||
| Number Of Shares Shorted | 8.83 K | ||||
| Price To Sales | 0.35 X | ||||
| Revenue | 50.32 K | ||||
| Gross Profit | 1.21 M | ||||
| EBITDA | (10.5 M) | ||||
| Net Income | (11.8 M) | ||||
| Total Debt | 638.99 K | ||||
| Book Value Per Share | (2.23) X | ||||
| Cash Flow From Operations | (4.39 M) | ||||
| Short Ratio | 0.27 X | ||||
| Earnings Per Share | (5.10) X | ||||
| Number Of Employees | 15 | ||||
| Beta | 0.37 | ||||
| Market Capitalization | 516.7 K | ||||
| Total Asset | 1.47 M | ||||
| Retained Earnings | (68.87 M) | ||||
| Working Capital | (4.92 M) | ||||
| Net Asset | 1.47 M |
About Longevity Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Longevity Health Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Longevity Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Longevity Health Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Longevity Health Holdings is a strong investment it is important to analyze Longevity Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Longevity Health's future performance. For an informed investment choice regarding Longevity Stock, refer to the following important reports:Check out You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Will Biotechnology sector continue expanding? Could Longevity diversify its offerings? Factors like these will boost the valuation of Longevity Health. Anticipated expansion of Longevity directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Longevity Health data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Longevity Health Holdings using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Longevity Health's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Longevity Health's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Longevity Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Longevity Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Longevity Health's market price signifies the transaction level at which participants voluntarily complete trades.